Royalty Pharma PLC (RPRX)
28.08
+0.11
(+0.39%)
USD |
NASDAQ |
May 10, 16:00
28.08
0.00 (0.00%)
After-Hours: 20:00
Royalty Pharma Price to Book Value: 1.922 for May 10, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 09, 2024 | 1.914 |
| May 08, 2024 | 1.916 |
| May 07, 2024 | 1.936 |
| May 06, 2024 | 1.950 |
| May 03, 2024 | 1.944 |
| May 02, 2024 | 1.968 |
| May 01, 2024 | 1.921 |
| April 30, 2024 | 1.896 |
| April 29, 2024 | 1.925 |
| April 26, 2024 | 1.916 |
| April 25, 2024 | 1.924 |
| April 24, 2024 | 1.915 |
| April 23, 2024 | 1.904 |
| April 22, 2024 | 1.904 |
| April 19, 2024 | 1.927 |
| April 18, 2024 | 1.909 |
| April 17, 2024 | 1.890 |
| April 16, 2024 | 1.879 |
| April 15, 2024 | 1.934 |
| April 12, 2024 | 1.932 |
| April 11, 2024 | 1.988 |
| April 10, 2024 | 2.016 |
| April 09, 2024 | 2.034 |
| April 08, 2024 | 2.001 |
| April 05, 2024 | 1.998 |
| Date | Value |
|---|---|
| April 04, 2024 | 1.966 |
| April 03, 2024 | 1.971 |
| April 02, 2024 | 2.015 |
| April 01, 2024 | 2.046 |
| March 28, 2024 | 2.079 |
| March 27, 2024 | 2.084 |
| March 26, 2024 | 2.069 |
| March 25, 2024 | 2.072 |
| March 22, 2024 | 2.072 |
| March 21, 2024 | 2.083 |
| March 20, 2024 | 2.081 |
| March 19, 2024 | 2.066 |
| March 18, 2024 | 2.057 |
| March 15, 2024 | 2.059 |
| March 14, 2024 | 2.043 |
| March 13, 2024 | 2.045 |
| March 12, 2024 | 2.077 |
| March 11, 2024 | 2.059 |
| March 08, 2024 | 2.079 |
| March 07, 2024 | 2.056 |
| March 06, 2024 | 2.036 |
| March 05, 2024 | 2.014 |
| March 04, 2024 | 2.046 |
| March 01, 2024 | 2.048 |
| February 29, 2024 | 2.077 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.877
Minimum
Sep 21 2023
4.324
Maximum
Dec 29 2020
2.921
Average
2.978
Median
May 20 2022
Price to Book Value Benchmarks
| Viatris Inc | 0.6475 |
| Amgen Inc | 33.13 |
| Arrowhead Pharmaceuticals Inc | 17.05 |
| Ironwood Pharmaceuticals Inc | -- |
| Maravai LifeSciences Holdings Inc | 3.329 |
Price to Book Value Related Metrics
| PE Ratio | 11.14 |
| PS Ratio | 7.190 |
| Price to Free Cash Flow | 5.666 |
| Price | 28.08 |
| Earnings Yield | 8.97% |
| Market Cap | 12.54B |
| Operating PE Ratio | 11.35 |
| Normalized PE Ratio | 14.07 |